NVE Q2 FY2027 revenue falls 8% to $5.83M
The board approved a $1.00 quarterly cash dividend, payable November 30, 2026, to shareholders of record November 2, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NVE Corporation (NVEC) reported second-quarter fiscal 2027 revenue of $5.83 million, down 8% from $6.35 million in the prior-year quarter. Product sales decreased 9%, while contract research and development revenue increased 25%. Net income was $3.17 million, or $0.65 per diluted share, compared with $3.31 million, or $0.68 per diluted share, a year earlier.
For the first six months of fiscal 2027, revenue increased 36% to $16.9 million from $12.5 million, reflecting increases of 35% in product sales and 38% in contract research and development revenue. Net income increased 39% to $9.57 million from $6.89 million, and diluted earnings per share were $1.97 versus $1.42. The board approved a $1.00 quarterly cash dividend per common share, payable November 30, 2026, to shareholders of record November 2, 2026.
At September 30, 2026, NVE reported cash and cash equivalents of $3.97 million, short-term marketable securities of $19.68 million, and long-term marketable securities of $20.74 million. Total assets were $59.86 million and total liabilities were $1.89 million.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointSix-month revenue increased 36% to $16.9 million year over year.
- Moderate pointSix-month net income increased 39% to $9.57 million year over year.
Negative
- Moderate pointSecond-quarter revenue decreased 8% to $5.83 million year over year.
8-K Event Classification
Key Figures
Key Terms
contract research and development revenue financial
spintronics technical
marketable securities financial
operating lease liability financial
Earnings Snapshot
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did NVEC perform in the second quarter and first half of fiscal 2027?
What dividend did NVEC approve?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
||
( |
(Zip Code) |
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
Furnished as Exhibit 99 is a press release of NVE Corporation reporting results for the quarter ended September 30, 2026.
Item 8.01. Other Events.
NVE Corporation announced that its Board of Directors approved a quarterly cash dividend to shareholders of $1.00 per share of common stock, payable November 30, 2026 to shareholders of record as of November 2, 2026.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date October 21, 2026 |
NVE CORPORATION
|
|
3
INDEX TO EXHIBITS
Exhibit # |
Description |
99 |
Press release of NVE Corporation reporting results for the quarter ended September 30, 2026 and announcing a quarterly dividend.
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
4
NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend
EDEN PRAIRIE, Minn.—October 21, 2026—NVE Corporation (Nasdaq: NVEC) announced financial results today for the quarter ended September 30, 2026.
Total revenue for the second quarter of fiscal 2027 decreased 8% to $5.83 million from $6.35 million for the prior-year quarter. The decrease was due to a 9% decrease in product sales, partially offset by a 25% increase in contract research and development revenue. Net income for the second quarter of fiscal 2027 decreased 4% to $3.17 million, or $0.65 per diluted share, compared to $3.31 million, or $0.68 per share, for the prior-year quarter.
For the first six months of fiscal 2027, total revenue increased 36% to $16.9 million from $12.5 million for the first six months of the prior year. The increase was due to a 35% increase in product sales and a 38% increase in contract research and development revenue. Net income increased 39% to $9.57 million, or $1.97 per diluted share, from $6.89 million, or $1.42 per share, for the first half of fiscal 2026.
The company also announced a quarterly cash dividend to shareholders of $1.00 per share of common stock, payable November 30, 2026 to shareholders of record as of November 2, 2026.
“We’re pleased to report a 36% increase in revenue for the six months ended September 30, 2026, compared to the prior-year period, despite an 8% decrease in revenue for the second quarter of fiscal 2027 compared to the prior-year quarter,” said NVE President and Chief Executive Officer Peter G. Eames, PhD.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.
Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks and uncertainties related to tariffs, customs, duties, and other trade barriers, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2026.
###
Contact: investor@nve.com
NVE CORPORATION (Unaudited) | |||||||
| Quarter Ended September 30, | ||||||
| 2026 |
| 2025 | ||||
Revenue | |||||||
Product sales | $ | 5,575,282 |
|
| $ | 6,138,772 |
|
Contract research and development |
| 259,420 |
|
|
| 208,220 |
|
Total revenue, net |
| 5,834,702 |
|
|
| 6,346,992 |
|
Cost of sales |
| 1,270,805 |
|
|
| 1,378,494 |
|
Gross profit |
| 4,563,897 |
|
|
| 4,968,498 |
|
Expenses |
|
|
|
|
|
|
|
Research and development |
| 727,345 |
|
|
| 873,470 |
|
Selling, general, and administrative |
| 630,314 |
|
|
| 436,919 |
|
Total expenses |
| 1,357,659 |
|
|
| 1,310,389 |
|
Income from operations |
| 3,206,238 |
|
|
| 3,658,109 |
|
Interest income |
| 474,727 |
|
|
| 484,330 |
|
Other income |
| - |
|
|
| 3,094 |
|
Income before taxes |
| 3,680,965 |
|
|
| 4,145,533 |
|
Provision for income taxes |
| 507,806 |
|
|
| 834,695 |
|
Net income | $ | 3,173,159 |
|
| $ | 3,310,838 |
|
Net income per share – basic | $ | 0.66 |
|
| $ | 0.68 |
|
Net income per share – diluted | $ | 0.65 |
|
| $ | 0.68 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
Basic |
| 4,842,050 |
|
|
| 4,837,166 |
|
Diluted |
| 4,850,910 |
|
|
| 4,839,243 |
|
| |||||||
| Six Months Ended Sept. 30, | ||||||
| 2026 |
| 2025 | ||||
Revenue | |||||||
Product sales | $ | 16,310,017 |
|
| $ | 12,047,342 |
|
Contract research and development |
| 558,742 |
|
|
| 404,294 |
|
Total revenue, net |
| 16,868,759 |
|
|
| 12,451,636 |
|
Cost of sales |
| 3,336,850 |
|
|
| 2,561,017 |
|
Gross profit |
| 13,531,909 |
|
|
| 9,890,619 |
|
Expenses |
|
|
|
|
|
|
|
Research and development |
| 1,673,927 |
|
|
| 1,593,701 |
|
Selling, general, and administrative |
| 1,385,908 |
|
|
| 855,559 |
|
Total expenses |
| 3,059,835 |
|
|
| 2,449,260 |
|
Income from operations |
| 10,472,074 |
|
|
| 7,441,359 |
|
Interest income |
| 924,647 |
|
|
| 982,538 |
|
Other income |
| - |
|
|
| 3,905 |
|
Income before taxes |
| 11,396,721 |
|
|
| 8,427,802 |
|
Provision for income taxes |
| 1,829,371 |
|
|
| 1,541,146 |
|
Net income | $ | 9,567,350 |
|
| $ | 6,886,656 |
|
Net income per share – basic | $ | 1.98 |
|
| $ | 1.42 |
|
Net income per share – diluted | $ | 1.97 |
|
| $ | 1.42 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
Basic |
| 4,839,621 |
|
|
| 4,837,166 |
|
Diluted |
| 4,848,187 |
|
|
| 4,839,049 |
|
NVE CORPORATION | |||
|
|
|
|
|
| (Unaudited) September 30, |
|
| March 31, |
| ||
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
| $ | 3,969,958 |
|
| $ | 1,714,040 |
|
Marketable securities, short-term |
|
| 19,678,659 |
|
|
| 18,125,060 |
|
Accounts receivable, net of allowance for credit losses of $15,000 |
|
| 3,005,928 |
|
|
| 3,408,941 |
|
Inventories, net |
|
| 6,860,310 |
|
|
| 7,082,821 |
|
Prepaid expenses and other assets |
|
| 1,541,483 |
|
|
| 1,860,415 |
|
Total current assets |
|
| 35,056,338 |
|
|
| 32,191,277 |
|
Fixed assets |
|
|
|
|
|
|
|
|
Machinery and equipment |
|
| 13,925,767 |
|
|
| 13,843,799 |
|
Leasehold improvements |
|
| 2,059,853 |
|
|
| 2,059,853 |
|
|
|
| 15,985,620 |
|
|
| 15,903,652 |
|
Less accumulated depreciation and amortization |
|
| 12,652,165 |
|
|
| 12,187,643 |
|
Net fixed assets |
|
| 3,333,455 |
|
|
| 3,716,009 |
|
Marketable securities, long-term |
|
| 20,739,953 |
|
|
| 23,678,452 |
|
Right-of-use asset – operating lease |
|
| 732,004 |
|
|
| 793,794 |
|
Total assets |
| $ | 59,861,750 |
|
| $ | 60,379,532 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
| $ | 252,399 |
|
| $ | 278,599 |
|
Accrued payroll and other |
|
| 751,695 |
|
|
| 697,611 |
|
Operating lease |
|
| 202,612 |
|
|
| 165,116 |
|
Total current liabilities |
|
| 1,206,706 |
|
|
| 1,141,326 |
|
Deferred tax liabilities |
|
| 9,990 |
|
|
| 248,284 |
|
Long-term operating lease liability |
|
| 668,708 |
|
|
| 740,423 |
|
Total liabilities |
|
| 1,885,404 |
|
|
| 2,130,033 |
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity |
|
|
|
|
|
|
|
|
Common stock |
|
| 48,441 |
|
|
| 48,372 |
|
Additional paid-in capital |
|
| 20,175,512 |
|
|
| 19,914,769 |
|
Accumulated other comprehensive loss |
|
| (452,080 | ) |
|
| (32,010 | ) |
Retained earnings |
|
| 38,204,473 |
|
|
| 38,318,368 |
|
Total shareholders’ equity |
|
| 57,976,346 |
|
|
| 58,249,499 |
|
Total liabilities and shareholders’ equity |
| $ | 59,861,750 |
|
| $ | 60,379,532 |
|